• Brent A Tinnel, Mark A Henderson, Thomas C Witt, Achilles J Fakiris, Robert M Worth, Paul M Des Rosiers, James W Edmondson, Robert D Timmerman, and Simon S Lo.
• Department of Radiation Oncology, Walter Reed Army Medical Center, Washington, DC, USA.
• Stereotact Funct Neurosurg. 2008 Jan 1; 86 (5): 292-6.

PurposeTo examine treatment outcomes of Gamma Knife-based stereotactic radiosurgery (GK-based SRS) for secretory pituitary adenomas.Materials And Methods25 patients were treated with GK-based SRS for secretory pituitary adenomas with >or=12 months of follow-up.ResultsFor prolactinomas, 2 of 4 patients (50%) showed normalization of serum prolactin at a mean time of 18 months. One of 4 had a >or=50% decrease but still abnormal prolactin levels. For adrenocorticotrophic hormone-secreting tumors, 6 of 12 patients (50%) showed normalization of their endocrine levels at a median of 10 months. An additional 2 (17%) had a >or=50% decrease. For growth hormone-secreting tumors, 4 of 9 patients (44%) showed normalization of endocrine levels at a median time of 30 months. Two patients (22%) had >or=50% lower but abnormal endocrine levels.ConclusionGK-based SRS provides a reasonable rate of endocrine normalization of secretory pituitary adenoma. The time to endocrine response is shorter than reported for fractionated external beam radiotherapy. There is a low risk of optic neuropathy.Copyright 2008 S. Karger AG, Basel.

36 keywords...

hide…